Company Overview of BELLUS Health (Innodia) Inc.
BELLUS Health (Innodia) Inc., a biotechnology company, develops and markets compunds for the treatment and prevention of obesity, type 2 diabetes, and associated diseases. The company's development products include Adyvia for the treatment of obesity. BELLUS Health (Innodia) Inc. was formerly known as Innodia Inc. As a result of acquisition by BELLUS Health Inc. Innodia Inc.'s name was changed. The company was founded in 2002 and is based in Laval, Canada. As of July 17, 2008, BELLUS Health (Innodia) Inc. operates as a subsidiary of BELLUS Health Inc.
500 Cartier Boulevard West
Laval, QC H7V 5B7
Founded in 2002
Key Executives for BELLUS Health (Innodia) Inc.
Similar Private Companies By Industry
|2007262 Ontario, Inc.||Americas|
|2056273 Ontario, Inc.||Americas|
|AB BioPharma Inc.||Americas|
|AbCelex Technologies Inc.||Americas|
|AbCellera Biologics Inc.||Americas|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact BELLUS Health (Innodia) Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.